海南省积压商品房转化为经济适用住房管理办法

上一篇: 铁路货车统计规则
下一篇: 宁夏回族自治区消防管理处罚办法

State Food and Drug Administration General Administration of Customs of the People’s Republic of China


Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)




(SFDA Decree No. 25)

The Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim), adopted by the State Food and Drug Administration, the General Administration of Customs of the People’s Republic of China and the General Administration of Sport of China, is hereby promulgated in the decree sequence number of the State Food and Drug Administration and shall come into force as of September 1, 2006.


Shao Mingli
Commissioner
State Food and Drug Administration

Mou Xinsheng
Minister
General Administration of Customs of the People’s Republic of China

Liu Peng
Minister
General Administration of Sport of China
July 28, 2006





Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)


Article 1 The Provisions are formulated with a view to standardizing the administration of import and export of anabolic agents and peptide hormones in accordance with the Drug Administration Law of the People’s Republic of China, Customs Law of People's Republic of China, Anti-doping Regulations and other relevant laws and administrative regulations.

Article 2 The State adopts license control on the import and export of anabolic agents and peptide hormones.

Article 3 The importer shall apply for the importation of anabolic agents and peptide hormones to the State Food and Drug Administration.

Article 4 For the importation of anabolic agents and peptide hormones for medical purpose, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Copy of the Import Drug License (or the Pharmaceutical Product License) (original or duplicate);
(4) Copy of the Drug Supply Certificate, Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importer; to import drug substance and intermediate preparations including preparations to be repackaged in China for their own needs, drug manufacturers shall submit copies of the Drug Manufacturing Certificate, Corporate Business License and Organization Code Certificate;
(5) Where holders of the Import Drug License (or the Pharmaceutical Product License) entrust other companies to export their drugs, they shall provide the authorization letter for export.

All copies mentioned above should be stamped with the official seal of the importer.

Article 5 For the importation of anabolic agents and peptide hormones for teaching and scientific research purposes, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Certificates of legitimate qualifications of users in China, calculation basis for the quantity of the drug in use and letter of guarantee issued by the user for legitimate use and management of the drug;
(4) Approval documents for relevant scientific research projects or approval documents of relevant competent authority;
(5) Where entrusted by users for importation, importers shall provide copies of the authorization agreement, the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importers.

All copies mentioned above should be stamped with the official seal of the importer.

Article 6 Where a enterprise in China entrusted by an overseas enterprise for contract manufacturing needs to import anabolic agents and peptide hormones, it shall provide materials required in Items (1), (3) and (5) of Paragraph 1 of Article 5, in addition, official documents to prove recorded by the local (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government.

All copies mentioned above should be stamped with the official seal of the importer.

Article 7 The State Food and Drug Administration shall decide whether or not to approve the import within 15 working days after receiving the application for import and the relevant materials. Where the application is approved, the State Food and Drug Administration shall issue the Import License for the drug; where the application is not approved, the State Food and Drug Administration shall give reasons in writing.

Article 8 The importer may declare to the customs of the ports where drug importation is permitted upon presenting the Import License for the drug issued by the State Food and Drug Administration. The customs shall clear the drug in the presence of the Import License for the drug.
The Drug Import Note is not required for import of anabolic agents and peptide hormones.

Article 9 To import anabolic agents and peptide hormones including those sold in China for the first time for medical purpose, the importer shall fill in the Import Drug Clearance Form timely after going through the import formalities and submit the following materials in duplicate to the (food and) drug regulatory department where the port of entry is located, upon presenting the original Import Drug License (or the Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug, to apply for the Notice of Import Drug Port Test:
(1) Copies of the Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the Import License for the drug;
(2) Copies of the Drug Manufacturing Certificate or Drug Supply Certificate, and Copy of the Business License for Enterprises as a Legal Person.
(3) Copy of the certificate of origin;
(4) Copy of the purchasing contract;
(5) Copies of packing list, bill of lading and freight invoice;
(6) Copy of the certificate of analysis;
(7) Format of drug insert sheet, package and label (except for drug substance and intermediate preparation);

All copies mentioned above should be stamped with the official seal of the importer.

Article 10 After checking the received Import Drug Clearance Form and relevant materials, the port (food and) drug regulatory department shall return the original Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug to the importer, and send the Notice of Import Drug Port Test, along with a copy of the dossier as prescribed in Article 9 of the Provisions, to the port drug testing institute on the same day.

After receiving the Notice of Import Drug Port Test, the port drug testing institute shall contact the importer within two working days and conduct sampling on the storage site. Upon the completion of the sampling, the mark “sampled” shall be stamped on the back of the first page of the original Import License for the drug, with the seal of sampling institute affixed.

Article 11 Anabolic agents and peptide hormones imported for teaching and research purposes or for the domestic manufacturing contracted by overseas enterprises are exempted from testing.

Article 12 The port (food and) drug regulatory department shall report timely to the State Food and Drug Administration in any of the following circumstances:
(1) The port (food and) drug regulatory department refuses to issue the Notice of Import Drug Port Test in accordance with the provisions in Article 17 of the Provisions for Import Drug (Decree No. 4 of the State Food and Drug Administration and the General Administration of Customs);
(2) The port (food and) drug testing institute refuses the sampling in accordance with the requirements in Article 25 of the Provisions for Import Drug.

The port (food and) drug regulatory department shall take mandatory administrative measures to seal up or seize all the imported drugs within the situations prescribed in the previous paragraph. It shall make the decision of allowing shipping back within seven days from the date of the seal-up or seizure, and inform the importer of applying for the Export License for the drug according to the export procedures for anabolic agents and peptide hormones prescribed in the Provisions and return all the import drugs to the original exporting country.

Where the importer fails to respond or make clear its intention to ship back the drugs within ten days after being informed of the decision, the sealed up or seized drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.

Article 13 For imported anabolic agents and peptide hormones out of specifications upon testing by the port drug testing institute, the importer shall provide a detailed report about the distribution and use of all the imported drugs to the port (food and) drug regulatory department where the importer is located within two days after receiving the Import Drug Test Report.

After receiving the Import Drug Test Report, the port (food and) drug regulatory departments shall take mandatory administrative measures to timely seal up or seize all the drugs and, within seven days, decide whether or not to place the case on file.

Where the importer fails to apply for a retesting within the specified timeline or the result of the retesting is still out of specifications, the port (food and) drug regulatory department shall make the decision of allowing shipping back and notify the importer to apply for the Export License for the drug according to export procedures for anabolic agents and peptide hormones prescribed in the Provisions to return all the imported drugs to the original exporting country. Where the importer fails to respond or make clear its intention to ship back the drugs within ten days from the date of receiving the decision, the drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.

Where the result of retesting is in compliance with the specifications, the port (food and) drug regulatory department shall remove the mandatory administrative measures of seal-up and seizure.

The port (food and) drug regulatory department shall handle the case according to the provisions in Paragraph 2, Paragraph 3 and Paragraph 4 of this Article and report the result to the State Food and Drug Administration, and, at the same time, notify the (food and) drug regulatory departments of provinces, autonomous regions and municipalities directly under the Central Government as well as other port (food and) drug regulatory departments.

Article 14 Where domestic drug manufacturers, distributors and medical institutions purchase imported anabolic agents and peptide hormones, the supplier shall provide copies of the Import Drug License (or Pharmaceutical Product License), the Import License for the drug and the Import Drug Test Report, and affix its official seal to the abovementioned copies.

Article 15 The exporter shall apply for exportation of anabolic agents and peptide hormones to the (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government, where it is located, and submit the following materials:
(1) Application Form for Drug Export;
(2) Original import permit (or its copy with notarization) provided by the drug regulatory authority of the importing country or region.
If the importing country or region has no license system in the importation of anabolic agents and peptide hormones, the exporter shall provide the official document (original) of the drug regulatory authority of the importing country or region to prove that the import of the drugs of this type is exempted from the import permit, along with one of the following documents:
a. Original official document (or its copy with notarization) granting import provided by the drug regulatory authority of the importing country or region;
b. Certificates of legitimate qualifications of importers and original supporting document (or its copy with notarization) proving legitimate use of the drug;
(3) Copy of the purchasing contract or order form (except for manufacturers that export their own products);
(4) Copy of the export contract or order form;
(5) Where the export drug is an approved one produced by a domestic manufacturer, the Drug Manufacturing Certificate and Business License for Enterprises as a Legal Person of the manufacturer and a copy of the approval document of the drug shall be provided;
Where the export drug is produced by a domestic enterprise under contract of an overseas enterprise, the exporter shall provide a copy of the official document to prove recorded by the local (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government.
(6) Copies of the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the exporter.

All copies mentioned above should be stamped with the official seal of the exporter.

Article 16 Where the drugs are to be shipped back in accordance with the requirements in Article 12 and Article 13 of the Provisions, the exporter shall provide the following materials to apply for the Export License for the drug:
(1) Documents proving the request for return of goods made by the original exporter of the exporting country;
(2) Import License for the drug.

Article 17 The (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government shall decide whether or not to approve the export within 15 working days after receiving the export application and relevant materials.

Where the application is approved, the regulatory department shall issue the Export License for the drug; where the application is not approved, the regulatory department shall give reasons in writing.

Where the Export License for the drug is applied for in accordance with the requirements in Article 16 of the Provisions, the issuing authority shall mark “return of the original goods” on the Export License for the drug.

Article 18 The exporter may go through the customs formalities upon presenting the Export License for the drug issued by the (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government. The customs shall clear the drug in the presence of the Export License for the drug.

Article 19 The importer and exporter shall provide one more sheet of customs declaration form and apply for sign-back of the sheet when going through the customs formalities. The customs shall stamp the “proof seal” on the sheet in the presence of the Import License for the drug and Export License for the drug. The customs shall charge the cost according to the relevant regulations for issuing certificates.

The importer and exporter shall return the first sheet of the Import License for the drug or Export License for the drug along with the customs declaration form with the seal of the customs, to the issuing regulatory department within one month after completing the import and export.

Where the importer or exporter conducts no relevant importation or exportation after obtaining the Import License for the drug and Export License for the drug, the importer or exporter shall return the original license to the issuing regulatory department within one month after expiration of the license.

Article 20 The validation of the Import License for the drug is one year; the validation of the Export License for the drug is no more than three months (valid within the calendar year).

“One license for one customs clearance” is implemented for the Import License for the drug and Export License for the drug. The license shall be used only once within the validation and its content shall not be altered. Where the import or export is postponed for some reasons, the importer or exporter may request for a new license once with the original one.

Article 21 Where the Import License for the drug or Export License for the drug is lost, the importer or exporter shall report the loss to the original issuing authority in writing immediately. After receiving the loss report, the original issuing authority shall notify the port customs and reissue the license if no harmful consequences are found through confirmation.

Article 22 The Import License for the drug and Export License for the drug are uniformly printed by the State Food and Drug Administration.

Article 23 Where anabolic agents and peptide hormones are imported or exported in the form of processing trade, the customs shall go through and supervise the clearance formalities upon presentation of the Import License for the drug or Export License for the drug. Those not exported for special reasons shall be transferred to and handled by the local (food and) drug regulatory department in accordance with relevant regulations, and the customs shall conduct the verification and cancellation procedures in the presence of relevant documents.

Article 24 Anabolic agents and peptide hormones entering or leaving between bonded zones, export processing zones, other special Customs controlling areas, Customs bonded and controlling areas, with overseas, or between the special Customs controlling areas and the Customs bonded and controlling areas are exempt from application for the Import License for the drug or Export License for the drug, and supervised by the Customs.

Import License for the drug shall be applied for anabolic agents and peptide hormones entering from bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas into other places in China.

Export License for the drug shall be applied for anabolic agents and peptide hormones entering bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas from other places of China.

Article 25 Where an individual carries or mails anabolic agents and peptide hormones, within a reasonable amount, into or out of China for medical needs, the customs shall clear the drugs in the presence of prescriptions of medical institutions in accordance with relevant regulations on prescriptions of the competent health department.

Article 26 Besides prescribed in the Provisions, the importation, port test, supervision and control of anabolic agents and peptide hormones for medical purpose are implemented with reference to requirements related to drug importation in the Provisions for Drug Importation.

Article 27 Anabolic agents and peptide hormones imported for medical purpose mentioned in the Provisions refer to the import anabolic agents and peptide hormones to be used for preparation production or to be marketed in China.

Importer refers to the importer specified on the Import License for the drug obtained in accordance with the Provisions.

Exporter refers to the exporter specified on the Export License for the drug obtained in accordance with the Provisions.

Article 28 These Provisions shall go into effect as of September 1, 2006. The Notice on Import and Export of Anabolic Agents and Peptide Hormones (Guo Shi Yao Jian An [2004] No. 474) issued by the State Food and Drug Administration on September 30, 2004 shall be annulled therefrom.


浙江省人大常委会


浙江省农作物病虫害防治条例
——（2010年9月30日浙江省第十一届人民代表大会常务委员会第二十次会议通过）


　　

第一章 总 则
第一条 为了预防和控制农作物病虫害危害，加强农业植物保护工作，保障农业生产和农产品质量安全，保护生态环境，促进农业和农村经济发展，根据《中华人民共和国农业法》、《中华人民共和国农产品质量安全法》等法律、行政法规的规定，结合本省实际，制定本条例。
第二条 本省行政区域内农作物病虫害的监测、预报、预防、治理及其监督管理，适用本条例。
第三条 农作物病虫害防治应当遵循预防为主、综合防治的方针，坚持农作物病虫害防治与保护生态环境、保障农产品质量安全并重的原则。
第四条 省、设区的市、县（市、区）人民政府（以下简称县级以上人民政府）应当加强对本行政区域内的农作物病虫害防治工作的领导，将农作物病虫害防治体系建设纳入国民经济和社会发展规划，建立并落实农作物病虫害灾害防控责任制度，加强植保机构和队伍建设，推进专业化统一防治工作。
乡（镇）人民政府、街道办事处应当根据农业生产需要，组织做好农作物病虫害防治工作，确定承担农作物病虫害防治指导工作的机构和人员，协助做好农作物病虫害监测预报设施建设与维护等工作。
县级以上人民政府应当将农作物病虫害监测、预防、灾害应急防控、绿色防治措施的推广等经费纳入财政预算。
第五条 县级以上农业主管部门主管本行政区域内的农作物病虫害防治工作。农业主管部门所属的植保机构具体承担农作物病虫害的监测、预报工作和农作物病虫害防治及农药安全使用的指导、监督等工作。
财政、科技、气象、工商行政管理、环境保护、质量技术监督、卫生、出入境检验检疫、广播电视、供销等部门按照各自职责，共同做好农作物病虫害防治的相关工作。
第六条 农村集体经济组织或者村民委员会应当组织做好本村农作物病虫害防治工作，确定农作物病虫害防治指导人员，督促和指导农业生产经营者做好农作物病虫害防治工作。
农业生产经营者应当加强农作物病虫害防治知识和技术的学习，依法做好农作物病虫害防治工作。
第七条 对在农作物病虫害防治工作中作出突出贡献的社会组织和个人，各级人民政府和有关部门应当予以表彰和奖励。
第二章 监测与预报
第八条 县级以上农业主管部门应当根据农作物病虫害防治体系建设的要求，加强农作物病虫害监测预报站点和信息系统建设，建立健全监测预报工作制度，保障监测预报工作的正常进行。
第九条 农作物病虫害监测预报站点的监测预报设施受法律保护，任何单位和个人不得擅自移动、占用或者损毁。
因重点工程建设等需要迁移农作物病虫害监测预报站点或者设施的，建设单位应当征得设立该监测预报站点或者设施的农业主管部门同意，并在其指导下进行重建。重建费用由建设单位承担。
第十条 需要在农田、果园等农业生产经营场所安装监测预报设施，或者实施监测预报活动的，农业生产经营者应当予以配合。
因安装农作物病虫害监测预报设施或者实施监测预报活动，给农业生产经营者造成经济损失的，应当给予补偿。
第十一条 植保机构应当按照农作物病虫害监测预报规范开展农作物病虫害监测。
农作物病虫害监测人员应当做好农作物病虫害的调查监测，及时准确提供监测数据。
县级植保机构可以根据需要临时聘用具备农作物病虫害监测技能的人员，协助开展调查监测工作。
农作物病虫害监测预报规范，由省农业主管部门制定。
第十二条 植保机构应当根据农作物病虫害监测数据，按照农作物病虫害监测预报规范，及时作出农作物病虫害发生趋势预测，无偿发布农作物病虫害预报预警信息，并提出农作物病虫害防治意见。
除植保机构外，任何单位和个人不得向社会发布农作物病虫害预报预警信息或者防治意见。
禁止伪造、变造农作物病虫害预报预警信息或者防治意见。
第十三条 农作物发生较大范围病虫害危害或者受到不明原因危害时，有关单位和个人应当及时向当地农业主管部门及其植保机构报告。
第十四条 气象部门应当及时进行农作物病虫害发生发展气象条件监测预测分析，发布农作物病虫害气象预报。气象部门与农业主管部门应当相互无偿提供用于农作物病虫害监测预报的气象信息和农作物病虫害监测预报信息。
广播电视、政府门户网站和省、设区的市人民政府指定的报纸等媒体，应当及时无偿播发、刊登植保机构发布的农作物病虫害预报预警信息。
第三章 预防与治理
第十五条 鼓励农业生产经营者通过采用抗病虫良种、合理的间作轮作、科学的田间管理等措施，减少农作物病虫害的发生。
农作物品种的抗病虫性应当作为农作物新品种审定的主要指标之一。
第十六条 县级以上农业主管部门应当根据农作物病虫害发生情况，及时组织和指导农业生产经营者对农作物病虫害实施有效的防治。
第十七条 农业生产经营者应当根据农业生产和病虫害发生情况，做好农作物病虫害的防治。植保机构发布农作物病虫害预报预警信息的，农业生产经营者应当根据植保机构提出的防治意见，及时进行农作物病虫害防治，按照规定做好病虫害防治记录。
第十八条 农业生产经营者不得使用国家禁止使用的农药及其他农作物病虫害防治产品。
使用化学农药防治农作物病虫害的，农业生产经营者应当优先选用低毒、低残留和对生态环境危害较轻的农药。
第十九条 县级以上农业主管部门根据养蚕、养蜂等产业安全生产和农产品质量安全要求，以及农作物病虫害抗药性情况，可以提出在特定区域、特定时段内以及对特定农作物限制使用的农药名录，报省农业主管部门批准并公布。
农业生产经营者不得违反前款规定使用农药。
第二十条 鼓励大专院校、科研单位和企业等开展农作物病虫害绿色防治技术和产品的研究开发。
鼓励农业生产经营者采用农业防治、生物防治、物理防治等绿色防治技术和产品进行农作物病虫害防治。
第二十一条 县级以上人民政府应当制定农作物病虫害专业化统一防治工作的推进目标和实施计划，并组织实施。
第二十二条 各级人民政府以及农业主管部门应当支持农作物病虫害专业化统一防治服务组织的建设。
农作物病虫害专业化统一防治服务组织应当依法办理工商登记手续，按照服务协议与防治技术规程为农业生产经营者提供农作物病虫害专业化统一防治服务。
第二十三条 农业生产经营企业和农民专业合作经济组织应当建立农作物病虫害专业化统一防治队伍或者委托专业化统一防治服务组织，对本单位的农作物病虫害实行专业化统一防治。
第二十四条 鼓励农村集体经济组织单独或者联合建立农作物病虫害专业化统一防治队伍，为农村集体经济组织成员提供农作物病虫害专业化统一防治服务。
鼓励农村集体经济组织成员参加农作物病虫害专业化统一防治。
第二十五条 各级人民政府应当根据本行政区域内农作物病虫害防治的实际需要，对下列农作物病虫害防治事项提供资金支持：
（一）水稻、茶叶、水果等农作物的农业生产经营者参加农作物病虫害专业化统一防治的；
（二）农业生产经营者采用生物农药、诱虫灯、性诱剂、防虫网等绿色防治技术和产品进行农作物病虫害防治的；
（三）农药生产企业对用于小面积种植农作物的农药进行申报登记的；
（四）农作物病虫害专业化统一防治服务组织为从业人员投保人身意外险的。
前款规定资金支持的具体办法，由省财政部门会同省农业主管部门制定。
第二十六条 县级以上人民政府应当组织农业、林业、渔业、环境保护、财政、交通运输、工商行政管理、出入境检验检疫、科技、铁路等部门按照规定职责采取有效措施，防止外来农业有害生物入侵。
对已经引进的有风险的农业生物和已经入侵的农业有害生物，县级以上农业主管部门应当会同林业、渔业、环境保护等部门，组织有关专家查明发生区域和危害情况，监测其发展趋势，提出相应的防控措施；对需要进行严格控制和扑灭的农业有害生物，县级以上人民政府应当组织农业等有关部门以及乡（镇）人民政府、街道办事处采取有效措施进行控制和扑灭。
对从境外引进可能产生生态危害的农作物种子、苗木和其他繁殖材料，省植物检疫机构应当在依法办理检疫审批手续时，对其进行生态危害风险评估，提出相应的处理意见。引进单位应当按照省植物检疫机构的风险评估及处理意见，做好相关工作。
第二十七条 县级以上人民政府应当按照分级负责的原则，制定农作物病虫害灾害应急预案（以下简称应急预案），落实农作物病虫害灾害防控物资储备。
发生农作物病虫害灾害时，县级以上农业主管部门应当及时向本级人民政府提出启动相应等级应急响应的建议，同时向上级农业主管部门报告。县级以上人民政府根据农业主管部门的建议和有关情况，适时启动相应等级的应急响应，并及时安排和调配控制、扑灭农作物病虫害灾害所需的资金和物资。
有关单位和个人应当按照应急预案的要求，做好农作物病虫害的控制和扑灭工作。
第二十八条 县级以上农业主管部门及其植保机构和农业技术推广机构，应当通过广播电视、互联网等媒体或者采用发放资料、集中授课等形式，加强农作物病虫害防治知识的宣传和普及，定期对农作物病虫害专业化统一防治服务组织、农业生产经营者以及农药经营者等进行农作物病虫害防治技术培训。
农作物病虫害防治技术培训不得收取培训费用，所需经费由同级财政保障。
第二十九条 植保机构及其工作人员不得从事下列行为：
（一）在农作物病虫害防治意见中指定所推介农药的生产单位；
（二）在农作物病虫害防治技术培训时以营利为目的，宣传、推介农作物病虫害防治产品；
（三）违反规定推广农作物病虫害防治新技术、新产品。
第四章 农药经营与使用
第三十条 农药经营实行许可制度。未经许可，任何单位和个人不得从事农药经营。
申领农药经营许可证，应当具备下列条件：
（一）有不少于一名的植保专业技术人员；
（二）有符合规定要求的销售、仓储场所和安全防护、环境保护等设施、设备；
（三）有相应的内部管理制度和员工业务培训制度；
（四）法律、法规规定的其他条件。
经营的农药属于危险化学品的，依照《危险化学品安全管理条例》的规定执行。
第三十一条 申领农药经营许可证的，应当向县级以上农业主管部门提出申请，并根据本条例第三十条第二款规定的条件提供相关材料。
县级以上农业主管部门应当自收到申请之日起十五个工作日内完成审查。经审查符合规定条件的，核发农药经营许可证；不符合规定条件的，应当书面告知并说明理由。
农药经营许可证格式，由省农业主管部门规定。
第三十二条 农药经营许可证有效期为三年。农药经营者需要延续农药经营许可证有效期的，应当在有效期届满三十日前向原发证机关提出申请。原发证机关应当在有效期届满前作出是否准予延续的决定；逾期未作决定的，视为准予延续。
第三十三条 农药经营者在销售农药时应当随货附送农药使用说明书，并正确介绍农药使用范围、防治对象、使用方法、安全间隔期和存放要求等注意事项，不得夸大农药的防治效果，不得误导农药使用者增加用药种类、用药次数和用药量。
农药经营者应当在经营场所张贴植保机构发布的农作物病虫害防治意见，公开农药使用咨询电话，及时解答有关询问。
禁止销售假农药、劣质农药。
第三十四条 农药经营者在销售农药时应当开具销售凭证，并建立购销台账，对产品来源、产品信息、销售信息进行记录。购销台账应当至少保存二年。
第三十五条 农药使用者应当遵守农药安全、合理使用的有关规定，按照农药使用说明书的要求正确配药、施药，并做好安全防护措施。农药使用者不得擅自增加用药次数和用药量。
施用过农药的农作物，应当在安全间隔期满后采收、出售。
第三十六条 植保机构、农业技术推广机构应当指导、督促农药使用者按照有关规定安全、合理使用农药，及时制止和纠正不符合农药使用安全间隔期规定的农作物采收行为。
第三十七条 农药经营者和使用者应当妥善保管农药及农药废弃包装物，不得随意丢弃。
废弃农药及农药废弃包装物实行集中回收和无害化处置，具体办法由省人民政府制定。
第三十八条 县级以上农业主管部门应当建立农药安全使用预警机制。发生农作物农药药害和农药使用安全事故时，农业、卫生主管部门应当会同有关部门及时进行调查和处置，按照规定将有关情况及时报本级人民政府以及上级主管部门，并通报相关部门。
第五章法律责任
第三十九条 违反本条例规定的行为，法律、法规已有行政处罚规定的，从其规定；构成犯罪的，依法追究刑事责任；造成他人财产损失或者人身损害的，依法承担赔偿责任。
第四十条 违反本条例第九条第一款规定，擅自移动、占用、损毁农作物病虫害监测预报设施的，由县级以上农业主管部门责令限期改正，恢复原状；逾期未改正的，代为恢复原状，费用由违法行为人承担，处五百元以上五千元以下的罚款。
第四十一条 违反本条例第十二条第二款、第三款规定，向社会发布农作物病虫害预报预警信息、防治意见，或者伪造、变造农作物病虫害预报预警信息、防治意见的，由县级以上农业主管部门责令停止违法行为，处一千元以上五千元以下的罚款。
第四十二条 违反本条例第十九条第二款规定，在特定区域、特定时段内或者对特定农作物使用限制使用的农药的，由县级以上农业主管部门责令停止违法行为，给予警告，并处二千元以上二万元以下的罚款。
第四十三条 违反本条例第二十六条第三款规定，从境外引进农作物种子、苗木和其他繁殖材料的单位未按照省植物检疫机构的风险评估及处理意见做好相关工作的，由省植物检疫机构责令改正；逾期未改正的，对引进的农作物种子、苗木和其他繁殖材料予以销毁，处五千元以上五万元以下的罚款。
第四十四条 违反本条例第三十条第一款规定，未经许可从事农药经营的，由县级以上农业主管部门责令停止经营，没收违法所得，并处二千元以上二万元以下的罚款。
第四十五条 违反本条例第三十三条第三款规定，销售假农药、劣质农药的，依照有关法律、法规的规定处理；情节严重的，由原发证机关并处吊销农药经营许可证。
第四十六条 农药经营者有下列行为之一的，由县级以上农业主管部门责令限期改正；逾期未改正的，处一千元以上一万元以下的罚款；情节严重的，由原发证机关并处吊销农药经营许可证：
（一）违反本条例第三十三条第一款规定，在销售农药时未随货附送农药使用说明书或者误导农药使用者增加用药种类、用药次数或者用药量的；
（二）违反本条例第三十四条规定，未建立农药购销台账或者未按照规定进行销售记录和保存购销台账的。
第四十七条 县级以上农业主管部门及其植保机构和其他部门有下列情形之一的，由本级人民政府或者上级人民政府有关部门责令改正，通报批评；对直接负责的主管人员和其他直接责任人员依法给予处分：
（一）未按照本条例规定核发农药经营许可证的；
（二）未按照农作物病虫害监测预报规范发布预报预警信息的；
（三）在农作物病虫害防治意见中指定所推介农药的生产单位的；
（四）未按照本条例规定进行农作物病虫害防治技术培训的；
（五）在农作物病虫害防治技术培训时以营利为目的，宣传、推介农作物病虫害防治产品的；
（六）其他玩忽职守、徇私舞弊、滥用职权的行为。
第六章 附 则
第四十八条 本条例下列用语的含义：
（一）农作物，是指粮食、棉花、油料、麻料、糖料、蔬菜、茶树、桑树、烟草、草类、绿肥、食用菌等作物，以及按照规定列入农作物范围的果树、花卉和中药材。
（二）农作物病虫害，是指对农作物产生危害的病（病原物）、虫（螨）、草、鼠、软体动物和其他有害生物。
（三）农作物病虫害灾害，是指对农作物造成重大危害和严重损失的虫害和流行性植物病害以及其他生物灾害，分为Ⅰ级（特别重大农作物病虫害灾害）、Ⅱ级（重大农作物病虫害灾害）、Ⅲ级（较大农作物病虫害灾害）。
（四）植保专业技术人员，是指取得中等职业教育及以上学历的植保及相关专业人员、具有与植保相关的初级以上技术职称的技术人员，以及取得职业技能鉴定证书的农业植保工。
第四十九条 林业、园林病虫害防治工作，依照有关法律、法规的规定执行。
第五十条 本条例施行前已经从事农药经营的，应当在本条例施行之日起一年内，具备本条例第三十条第二款规定的条件，并向县级以上农业主管部门申领农药经营许可证。
第五十一条 本条例自2011年1月1日起施行。